Clinical Trials
Catalent Biologics Completes Madison Facility Expansion to Double Clinical and Commercial Drug Substance Capacity
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it has completed the expansion of two new suites at its biologics drug...
Packaging & Labelling
CEVA Logistics launches FORPATIENTS healthcare logistics sub-brand, new temperature-sensitive solution
In an expansion of its support for global healthcare and pharmaceutical customers, CEVA Logistics announced today, on World Health Day, a new sub-brand to support better patient outcomes through the company’s broad range of healthcare logistics services. CEVA FORPATIENTS...
Clinical Trials
Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients
Eli Lilly and Company and Incyte announced results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily plus standard of care (SoC) versus placebo plus SoC. The trial did not meet statistical significance on the primary...
Packaging & Labelling
FedEx Distribution of COVID-19 Vaccines Grows, Reaches 100 Million Vaccine Doses Delivered
For more than a year, FedEx has been on the frontlines of the COVID-19 pandemic, delivering pharmaceuticals, personal protective equipment, critical medical supplies and e-commerce shipments to communities around the world impacted by this pandemic.
Today, we mark an important...
Clinical Trials
Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial
Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, announced the engagement of IQVIA Biotech, a contract research organization (CRO) to manage the Company's effort to begin...
Drug Research
Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Moderna’s COVID-19 Vaccine and Clinical Portfolio
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced...
Packaging & Labelling
Moderna Announces Shipment of 100 Millionth Dose of its COVID-19 Vaccine to the U.S. Government
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Company has shipped the 100-millionth dose of its COVID-19 vaccine to the U.S. Government. More than 67 million doses of the Moderna COVID-19 Vaccine...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read